The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from ...

People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.

Retatrutide, an experimental injectable drug, targets three hormones related to weight loss.

MEDVi offers GLP-1 weight loss drugs online, but is it worth it? Review pricing, pros, cons, and what customers have to say.

Eli Lilly’s highly anticipated new weight loss drug, retatrutide, helped people lose up to 30% of their body weight, about 85 ...

A study in mice showed how T2D drug metformin exerts multiple clinical effects through selective inhibition of mitochondrial ...

Explore the potential benefits and risks of using type 2 diabetes drugs like Ozempic and metformin off-label to manage weight ...

A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart ...

Participants on weekly injections of 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks, and 45.3% of participants achieved ≥ 30% weight loss.

Retatrutide helped people lose 70 pounds on average, or 28% of their body weight, in a clinical trial. The Eli Lilly weight-loss drug mimics three gut hormones.

Retatrutide, Eli Lilly's new experimental drug, helped some participants lose up to 28 percent of their body weight in ...

A common side effect of many GLP-1 drugs is hair loss. It's creating a growing market for hair treatment products. Companies like Redken, Nutrafol and KeraFactor are leaning into the innovation and ...